Arbutus Biopharma Corp (NASDAQ: ABUS) on Tuesday, soared 7.14% from the previous trading day, before settling in for the closing price of $3.22. Within the
On Tuesday, Arbutus Biopharma Corp (NASDAQ: ABUS) opened lower -5.41% from the last session, before settling in for the closing price of $3.51. Price fluctuations
A new trading day began on Tuesday, with Arbutus Biopharma Corp (NASDAQ: ABUS) stock price up 2.10% from the previous day of trading, before settling
Arbutus Biopharma Corp (NASDAQ: ABUS) kicked off on Monday, up 4.46% from the previous trading day, before settling in for the closing price of $3.14.
Arbutus Biopharma Corp (NASDAQ: ABUS) started the day on Wednesday, with a price increase of 10.07% at $3.17, before settling in for the price of
Arbutus Biopharma Corp (NASDAQ: ABUS) kicked off on Friday, down -7.98% from the previous trading day, before settling in for the closing price of $3.51.
On Tuesday, Arbutus Biopharma Corp (NASDAQ: ABUS) was -0.29% drop from the session before settling in for the closing price of $3.49. A 52-week range
Arbutus Biopharma Corp (NASDAQ: ABUS) open the trading on Thursday, with a bit cautious approach as it glided -2.39% to $3.27, before settling in for
On Monday, Arbutus Biopharma Corp (NASDAQ: ABUS) was 3.35% up from the session before settling in for the closing price of $3.28. A 52-week range
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.